BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $1.13 and traded as low as $1.09. BioRestorative Therapies shares last traded at $1.10, with a volume of 15,168 shares.
BioRestorative Therapies Trading Down 4.3%
The stock has a market cap of $9.76 million, a PE ratio of -0.75 and a beta of 0.28. The firm has a fifty day simple moving average of $1.13 and a two-hundred day simple moving average of $1.38.
About BioRestorative Therapies
BioRestorative Therapies, Inc (OTCMKTS:BRTX) is a clinical-stage biotechnology company dedicated to developing regenerative medicine therapies for urological, orthopedic and rehabilitative indications. The company’s research focuses on autologous and allogeneic cell therapy platforms designed to repair, regenerate and restore normal tissue function through targeted cell delivery and expansion technologies.
Among its lead programs is BRTX-100, an investigational autologous muscle cell therapy aimed at treating stress urinary incontinence, which is advancing through late-stage clinical studies.
Read More
- Five stocks we like better than BioRestorative Therapies
- Your Bank Account Is No Longer Safe
- Ray Dalio Says Buy Gold. I Say Get Paid Every Month From It
- [No Brainer Gold Play]: “Show me a better investment.”
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
